Arrowhead Pharmaceuticals Inc (ARWR)
24.44
+0.31
(+1.28%)
USD |
NASDAQ |
May 03, 16:00
24.44
0.00 (0.00%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Free Cash Flow: -402.70M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -402.70M |
| September 30, 2023 | -330.63M |
| June 30, 2023 | -342.91M |
| March 31, 2023 | -353.21M |
| December 31, 2022 | -236.25M |
| September 30, 2022 | -188.91M |
| June 30, 2022 | -119.69M |
| March 31, 2022 | -74.88M |
| December 31, 2021 | 123.85M |
| September 30, 2021 | 147.74M |
| June 30, 2021 | 166.83M |
| March 31, 2021 | 164.80M |
| December 31, 2020 | -123.10M |
| September 30, 2020 | -107.75M |
| June 30, 2020 | -88.63M |
| March 31, 2020 | -45.76M |
| December 31, 2019 | -34.36M |
| September 30, 2019 | 161.03M |
| June 30, 2019 | 151.66M |
| March 31, 2019 | 129.75M |
| December 31, 2018 | 133.73M |
| September 30, 2018 | -48.64M |
| June 30, 2018 | -54.57M |
| March 31, 2018 | -51.53M |
| December 31, 2017 | -51.39M |
| Date | Value |
|---|---|
| September 30, 2017 | -31.86M |
| June 30, 2017 | -35.44M |
| March 31, 2017 | -42.87M |
| December 31, 2016 | -42.03M |
| September 30, 2016 | -68.29M |
| June 30, 2016 | -68.25M |
| March 31, 2016 | -62.65M |
| December 31, 2015 | -64.48M |
| September 30, 2015 | -67.68M |
| June 30, 2015 | -66.21M |
| March 31, 2015 | -63.23M |
| December 31, 2014 | -54.75M |
| September 30, 2014 | -37.13M |
| June 30, 2014 | -31.25M |
| March 31, 2014 | -26.32M |
| December 31, 2013 | -22.62M |
| September 30, 2013 | -19.33M |
| June 30, 2013 | -18.51M |
| March 31, 2013 | -17.02M |
| December 31, 2012 | -16.89M |
| September 30, 2012 | -15.82M |
| June 30, 2012 | -12.81M |
| March 31, 2012 | -9.832M |
| December 31, 2011 | -6.752M |
| September 30, 2011 | -5.400M |
Free Cash Flow Range, Past 5 Years
-402.70M
Minimum
Dec 2023
166.83M
Maximum
Jun 2021
-80.68M
Average
-88.63M
Median
Jun 2020
Free Cash Flow Benchmarks
| Madrigal Pharmaceuticals Inc | -325.71M |
| Viking Therapeutics Inc | -54.87M |
| Akero Therapeutics Inc | -145.37M |
| 89bio Inc | -129.19M |
| Sagimet Biosciences Inc | -23.77M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -117.84M |
| Cash from Investing (Quarterly) | 64.84M |
| Cash from Financing (Quarterly) | 0.267M |
| Free Cash Flow Per Share (Quarterly) | -1.736 |
| Free Cash Flow to Equity (Quarterly) | -186.50M |
| Free Cash Flow to Firm (Quarterly) | -183.99M |
| Free Cash Flow Yield | -15.34% |